PortfoliosLab logoPortfoliosLab logo
CSL Ltd (CSLLY)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US12637N2045

Highlights

Market Cap
$23.87B
Enterprise Value
$36.01B
EPS (TTM)
$4.30
PE Ratio
5.71
PEG Ratio
0.81
Total Revenue (TTM)
$30.52B
Gross Profit (TTM)
$15.22B
EBITDA (TTM)
$9.90B
Year Range
$22.83 - $44.86
Target Price
$307.00
ROA (TTM)
11.03%
ROE (TTM)
22.41%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CSL Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in CSL Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

CSL Ltd (CSLLY) has returned -12.57% so far this year and -35.55% over the past 12 months. Over the last ten years, CSLLY has returned 4.12% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


CSL Ltd

1D
2.21%
1M
-3.36%
YTD
-12.57%
6M
-23.11%
1Y
-35.55%
3Y*
-18.42%
5Y*
-11.83%
10Y*
4.12%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Nov 19, 2008, CSLLY's average daily return is +0.06%, while the average monthly return is +1.04%. At this rate, your investment would double in approximately 5.6 years.

Historically, 54% of months were positive and 46% were negative. The best month was Nov 2023 with a return of +17.6%, while the worst month was Aug 2025 at -20.4%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 7 months.

On a daily basis, CSLLY closed higher 51% of trading days. The best single day was Mar 13, 2020 with a return of +22.0%, while the worst single day was Aug 19, 2025 at -17.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20269.29%-17.22%-3.36%-12.57%
2025-1.55%-5.61%-2.01%1.63%-0.75%-0.70%9.90%-20.35%-4.41%-12.03%5.99%-5.69%-32.89%
20240.99%-5.38%2.14%-4.97%5.19%4.51%3.58%2.21%-4.58%-5.09%-2.01%-4.70%-8.71%
20238.09%-5.47%-2.52%3.26%0.20%-7.70%-2.55%-1.91%-7.74%-8.62%17.56%12.01%0.93%
2022-12.60%2.64%5.68%-4.49%2.13%-5.45%10.59%-1.32%-8.58%-2.03%14.79%-4.94%-6.75%
2021-5.53%-1.36%-0.87%3.07%7.23%-4.97%0.05%7.13%-7.68%8.58%-3.74%-3.31%-2.97%

Benchmark Metrics

CSL Ltd has an annualized alpha of 3.09%, beta of 0.85, and R² of 0.26 versus S&P 500 Index. Calculated based on daily prices since November 20, 2008.

  • This stock participated in 84.34% of S&P 500 Index downside but only 78.86% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.26 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
3.09%
Beta
0.85
0.26
Upside Capture
78.86%
Downside Capture
84.34%

Return for Risk

Risk / Return Rank

CSLLY ranks 8 for risk / return — in the bottom 8% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


CSLLY Risk / Return Rank: 88
Overall Rank
CSLLY Sharpe Ratio Rank: 44
Sharpe Ratio Rank
CSLLY Sortino Ratio Rank: 88
Sortino Ratio Rank
CSLLY Omega Ratio Rank: 66
Omega Ratio Rank
CSLLY Calmar Ratio Rank: 1212
Calmar Ratio Rank
CSLLY Martin Ratio Rank: 1212
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for CSL Ltd (CSLLY) and compare them to a chosen benchmark (S&P 500 Index).


CSLLYBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.99

0.90

-1.88

Sortino ratio

Return per unit of downside risk

-1.19

1.39

-2.57

Omega ratio

Gain probability vs. loss probability

0.81

1.21

-0.40

Calmar ratio

Return relative to maximum drawdown

-0.80

1.40

-2.20

Martin ratio

Return relative to average drawdown

-1.40

6.61

-8.01

Explore CSLLY risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

CSL Ltd provided a 4.30% dividend yield over the last twelve months, with an annual payout of $1.06 per share. The company has been increasing its dividends for 7 consecutive years.


1.00%1.50%2.00%2.50%3.00%3.50%$0.00$0.20$0.40$0.60$0.8020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$1.06$0.73$0.64$0.59$0.56$0.56$0.49$0.41$0.38$0.47$0.63$0.28

Dividend yield

4.30%2.53%1.45%1.21%1.14%1.05%0.89%0.85%1.18%1.72%3.45%1.46%

Monthly Dividends

The table displays the monthly dividend distributions for CSL Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.65$0.65
2025$0.00$0.00$0.33$0.00$0.00$0.00$0.00$0.00$0.41$0.00$0.00$0.00$0.73
2024$0.00$0.00$0.27$0.00$0.00$0.00$0.00$0.00$0.36$0.00$0.00$0.00$0.64
2023$0.00$0.00$0.27$0.00$0.00$0.00$0.00$0.00$0.32$0.00$0.00$0.00$0.59
2022$0.00$0.00$0.26$0.00$0.00$0.00$0.00$0.00$0.30$0.00$0.00$0.00$0.56
2021$0.00$0.00$0.26$0.00$0.00$0.00$0.00$0.00$0.30$0.00$0.00$0.00$0.56

Dividend Yield & Payout


Dividend Yield

CSL Ltd has a dividend yield of 4.30%, which is quite average when compared to the overall market.

Payout Ratio

CSL Ltd has a payout ratio of 67.99%, which is quite average when compared to the overall market. This suggests that CSL Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the CSL Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CSL Ltd was 55.41%, occurring on Mar 18, 2026. The portfolio has not yet recovered.

The current CSL Ltd drawdown is 54.31%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-55.41%Nov 10, 20211091Mar 18, 2026
-31.42%Apr 11, 2011115Sep 22, 2011142Apr 17, 2012257
-30.33%Feb 20, 202022Mar 20, 2020166Nov 13, 2020188
-27.49%Mar 30, 201041May 26, 2010113Nov 4, 2010154
-25.66%Aug 28, 201882Dec 24, 2018176Sep 6, 2019258

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of CSL Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how CSL Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for CSLLY, comparing it with other companies in the Biotechnology industry. Currently, CSLLY has a P/E ratio of 5.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for CSLLY compared to other companies in the Biotechnology industry. CSLLY currently has a PEG ratio of 0.8. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CSLLY relative to other companies in the Biotechnology industry. Currently, CSLLY has a P/S ratio of 0.8. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CSLLY in comparison with other companies in the Biotechnology industry. Currently, CSLLY has a P/B value of 1.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items